Skip to Content

RDY 354 (Rivastigmine tartrate 4.5 mg)

Pill imprint RDY 354 has been identified as Rivastigmine tartrate 4.5 mg.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rivastigmine tartrate 4.5 mg RDY 354
Rivastigmine tartrate 4.5 mg RDY 354
Discount Card Promo
Rivastigmine tartrate
RDY 354
4.5 mg
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Dr. Reddy's Laboratories Ltd.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.